You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 5,583,114


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,583,114
Title: Adhesive sealant composition
Abstract:This invention is related to an adhesive composition which may be used to bond or seal tissue in vivo. The adhesive composition is readily formed from a two component mixture which includes a first part of a protein, preferably a serum albumin protein, in an aqueous buffer having a pH in the range of about 8.0-11.0 and a second part of a water-compatible or water-soluble bifunctional crosslinking agent. When the two parts of the mixture are combined, the mixture is initially a liquid which cures in vivo on the surface of tissue in less than about one minute to give a strong, flexible, pliant substantive composition which bonds to the tissue and is absorbed in about four to sixty days. The adhesive composition may be used either to bond tissue, to seal tissue or to prevent tissue adhesions caused by surgery.
Inventor(s): Barrows; Thomas H. (Cottage Grove, MN), Lewis; Terry W. (Woodbury, MN), Truong; Myhanh T. (Blaine, MN)
Assignee: Minnesota Mining and Manufacturing Company (Saint Paul, MN)
Application Number:08/281,473
Patent Claims:1. An adhesive composition consisting essentially of

i) a first aqueous mixture of about 20-60 wt/vol % serum albumin in about 0.01-0.25 molar buffer at a pH in a range of about 8.0-11.0,

ii) a second aqueous mixture of about 50-800 mg/ml of a crosslinking agent having a molecular weight in a range of about 1,000-15,000, wherein the crosslinking agent is of the formula

wherein --PEG-- is a diradical fragment represented by the formula

where a is an integer from 20-300;

wherein --LM-- is a diradical fragment selected from the group consisting of a carbonate diradical of the formula, --C(O)--, a monoester diradical of the formula, --(CH.sub.2).sub.b C(O)-- where b is an integer from 1-5, a diester diradical of the formula, --C(O)--(CH.sub.2).sub.c --C(O)-- where c is an integer from 2-10 and where the aliphatic portion of the diradical may be saturated or unsaturated, a dicarbonate diradical of the formula --C(O)--O--(CH.sub.2).sub.d --O--C(O)-- where d is an integer from 2-10, and an oligomeric diradical represented by the formulas --R--C(O)--, --R--C(O)--(CH.sub.2).sub.c --C(O)--, or --R--C(O)--O--(CH.sub.2).sub.d --O--C(O)-- where c is an integer from 2-10, d is an integer from 2-10, and R is a polymer or copolymer having 1-10 monomeric fragments selected from the group consisting of lactide, glycolide, trimethylene carbonate, caprolactone and p-dioxanone; and

wherein --G is a leaving group selected from the group consisting of succinimidyl, maleimidyl, phthalimidyl, imidazolyl, nitrophenyl or tresyl, and

wherein a combination of the first and second mixtures is initially liquid and then cures on the surface of tissue to give a flexible, substantive matrix which bonds to the tissue and has a burst strength greater than about 10 mmHg.

2. The adhesive mixture of claim 1 wherein the protein in the first mixture is about 35-45 wt/vol % serum albumin.

3. The adhesive composition of claim 1 wherein the serum albumin is human serum albumin.

4. The adhesive composition of claim 1 wherein the buffer is 0.05-0.15 molar carbonate/bicarbonate buffer at a pH of about 9.0-10.5.

5. The adhesive composition of claim 1 wherein the second aqueous mixture is about 50-300 mg/ml of a crosslinking agent having a molecular weight in a range of about 1,000-5,000.

6. The adhesive composition of claim 1 wherein the ratio of a volume of the first mixture to a volume of the second mixture is in a range of about 1:10 to about 10:1.

7. The adhesive composition of claim 1 wherein --LM-- is an oligomeric diradical --R--C(O)--(CH.sub.2).sub.c --C(O)-- where c is an integer from 2-10 and R is a polymer or copolymer having 1-10 monomeric fragments selected from the group consisting of lactide, glycolide, trimethylene carbonate, caprolactone and p-dioxanone.

8. The adhesive composition of claim 1 wherein --G is succinimidyl.

9. An in vivo method of adhering tissue comprising the steps of topically applying and bonding an adhesive mixture of claim 1 to the tissue.

10. An in vivo method of sealing air leaks in pulmonary tissues comprising the step of topically applying and curing the adhesive mixture of claims 1 to an air leak site in the pulmonary tissue.

11. An in vivo method to prevent post-surgical adhesions comprising the step of topically applying and curing the adhesive mixture of claims 1 to tissue surrounding a surgical site.

12. An in vivo method to seal tissue comprising the step of topically applying and bonding the adhesive mixture of claims 1 to tissue to prevent or control blood or other fluid leaks.

13. The adhesive composition of claim 1 wherein the second aqueous mixture is about 300-800 mg/ml of a crosslinking agent having a molecular weight in a range of about 5,000-15,000.

14. The adhesive composition of claim 13 wherein --LM-- is a diester diradical of the formula --C(O)--(CH.sub.2).sub.2 --C(O)--.

15. The adhesive mixture of claim 1 wherein --LM-- is a diester diradical of the formula, --C(O)--(CH.sub.2).sub.c --C(O)-- where c is an integer from 2-10 and where the aliphatic portion of the diradical may be saturated or unsaturated.

16. The adhesive composition of claim 15 wherein --LM-- is a oligomeric diradical derived from polyglycolic acid.

17. A method of making a tissue adhesive consisting of the step of forming a mixture of

i) a first aqueous mixture of about 20-60 wt/vol % serum albumin in about 0.01-0.25 molar buffer at a pH in a range of about 8.0-11.0,

ii) a second aqueous mixture of about 50-800 mg/ml of a crosslinking agent having a molecular weight in a range of about 1,000-15,000, wherein the crosslinking agent is of the formula

wherein --PEG-- is a diradical fragment represented by the formula

where a is an integer from 20-300;

wherein --LM-- is a diradical fragment selected from the group consisting of a carbonate diradical of the formula, --C(O)--, a monoester diradical of the formula, --(CH.sub.2).sub.b C(O)-- where b is an integer from 1-5, a diester diradical of the formula, --C(O)--(CH.sub.2).sub.c --C(O)-- where c is an integer from 2-10 and where the aliphatic portion of the diradical may be saturated or unsaturated, a dicarbonate diradical of the formula --C(O)--O--(CH.sub.2).sub.d --O--C(O)-- where d is an integer from 2-10, and an oligomeric diradical represented by the formulas --R--C(O)--, --R--C(O)--(CH.sub.2).sub.c --C(O)--, or --R--C(O)--O--(CH.sub.2).sub.d --O--C(O)-- where c is an integer from 2-10, d is an integer from 2-10, and R is a polymer or copolymer having 1-10 monomeric fragments selected from the group consisting of lactide, glycolide, trimethylene carbonate, caprolactone and p-dioxanone; and

wherein --G is a leaving group selected from the group consisting of succinimidyl, maleimidyl, phthalimidyl, imidazolyl, nitrophenyl or tresyl, and

wherein a combination of the first and second mixtures is initially liquid and then cures on the surface of tissue to give a flexible, substantive matrix which bonds to the tissue and has a burst strength greater than about 10 mmHg.

Details for Patent 5,583,114

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 10/21/1942 ⤷  Try a Trial 2040-01-28
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 03/03/1954 ⤷  Try a Trial 2040-01-28
Csl Behring Ag ALBURX albumin (human) Injection 102366 07/23/1976 ⤷  Try a Trial 2040-01-28
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 08/15/1978 ⤷  Try a Trial 2040-01-28
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 02/17/1995 ⤷  Try a Trial 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.